Therapeutic interventions aiming to alleviate cognitive impairments have thus targeted ACh regulation and degradation; acetylcholinesterase (AChE) inhibitors blocking ACh hydrolysis have been administered to treat amnesia [3] and are widely prescribed to alleviate general cognitive decline [4]. The gene discussed is ACHE; the disease is amnesia.